Aerin Medical Wins FDA Approval for Nonsurgical Chronic Rhinitis Procedure Aerin Medical, a company that develops in minimally invasive, nonsurgical treatments for chronic nasal airway conditions, announces FDA clearance for the RhinAer™ Stylus designed to treat chronic rhinitis. According to the company’s press release, over 30 million Americans suffer from nonallergic rhinitis. Symptoms can vary
Aerin Medical Wins FDA Approval for Nonsurgical Chronic Rhinitis Procedure
